Alphagan P ALPHAGAN P - Prescribing Info PDF
Font SizeSize 1Size 2Size 3right
Get Adobe Acrobat Reader
Your Treatment
Your Treatments
Safety Information
Frequently Asked Questions
Compliance
Frequently Asked Questions
 
What is ALPHAGAN® P?
Will ALPHAGAN® P cure my glaucoma?
How do I use ALPHAGAN® P?
What are the most common side effects of ALPHAGAN® P?
What can I do to manage my elevated IOP?

What is ALPHAGAN® P?
ALPHAGAN® P ophthalmic solution is an eye medication that's proven to lower elevated intraocular pressure (IOP). Lowering IOP is the only treatable risk factor to prevent glaucomatous vision loss.

Will ALPHAGAN® P cure my glaucoma?
No. There is no cure for glaucoma. But keeping your IOP low and under control by taking your eye medication as prescribed is one of the best things you can do to help protect from glaucomatous vision loss.

How do I use ALPHAGAN® P?
Take ALPHAGAN® P opthalmic solution exactly as your eye doctor prescribed. ALPHAGAN® P ophthalmic solution may be used with other topical drug products to lower IOP. If you are taking more than 1 eye medication, administer them at least 5 minutes apart.

What are the most common side effects of ALPHAGAN® P?
The most common side effects of ALPHAGAN® P are allergic conjunctivitis, eye redness (hyperemia), and itchy eyes.

What can I do to manage my elevated IOP?
The best thing you can do to manage your elevated IOP is to stay on your medication and take ALPHAGAN® P ophthalmic solution exactly as your eye care professional prescribed. You should talk to your eye care professional before you stop taking ALPHAGAN® P.


  
spacer
ALPHAGAN® P ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
 
Important Safety Information
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.1% should not be used in patients receiving monoamine oxidase (MAO) inhibitor therapy. Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, ocular redness, and itching. Adverse events occurring in approximately 5% to 9% included: burning sensation, increased ocular lymph nodules, increased ocular pressure, ocular allergic reaction, dry mouth, and blurred vision.

Please click here for full Prescribing Information.
spacer
Allergan©2008 Allergan, Inc., Irvine, CA 92612  |  ® marks owned by Allergan, Inc.  |  www.allergan.com
Privacy Statement  |  Site Map